$57,722.51 research Payment -- Boehringer Ingelheim to Dr. Catherine Morris

This page provides a detailed analysis of a $57,722.51 research payment from Boehringer Ingelheim to Dr. Catherine Morris. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$57,722.51
Payment Typeresearch
Payment NatureResearch
Pharmaceutical CompanyBoehringer Ingelheim
PhysicianDr. Catherine Morris
NPI Number1246586937
Physician SpecialtyInternal Medicine
LocationCity, CO
Date of Payment2025-09-19
Related Drug/DeviceIbrance

Understanding research Payments

Research payments fund clinical trials, research studies, and investigator-initiated research conducted by physicians. These payments are often the largest category and represent a critical part of the drug development process. Research funding is generally considered the most legitimate form of pharmaceutical payment, though potential conflicts of interest can still arise when researchers have financial relationships with the companies whose products they study.

Related Reports

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.